TPG Pace Beneficial II Prices $350M IPO

TPGPace Beneficial II priced its IPO of 35 million Class A ordinary shares at $10 each.

Shares begin trading today on the NYSE under YTPG.

The offering is expected to close April 16.

The SPAC is focused on companies that combine attractive business fundamentals with, or with the potential for, strong environmental, social and governance policies. Read more.

Total
0
Shares
Related Posts
Read More

Phoenix Biotech Receives Nasdaq Warning

Phoenix in June signed a merger agreement with CERo Therapeutics at a pro forma equity capitalization of $145 million. The target is an immunotherapy company seeking to advance the next generation of engineered T cell therapeutics that employ phagocytic mechanisms.